Alterola Biotech, Inc.
CIK 0001442999
Revenue (TTM)
$0
Q2 Nov 2024
Net Income (TTM)
−$3.59M
−14.6% YoY
Q2 Nov 2024
EPS Diluted (TTM)
$0.00
Q2 Nov 2024
Gross Margin
—
Q2 Nov 2024
Operating Margin
—
Q2 Nov 2024
Net Margin
—
Q2 Nov 2024
Free Cash Flow (TTM)
−$113.18K
Q2 Nov 2024
Cash
$82.72K
Q2 Nov 2024
Total Debt
$0
Q2 Nov 2024
Shares Outstanding
1.46B sh
Q2 Nov 2024
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.